Chlorin E6 Conjugated Methoxy-Poly(Ethylene Glycol)-Poly(D,L-Lactide) Glutathione Sensitive Micelles for Photodynamic Therapy
Overview
Authors
Affiliations
Purpose: In this study, we developed a polymeric micellar system for glutathione-mediated intracellular delivery of a photosensitizer, chlorin e6 (Ce6) by synthesizing an amphiphilic polymer, methoxy-poly(ethylene glycol)-poly(D,L-lactide)-disulfide-Ce6 (mPEG-PLA-S-S-Ce6), which self-assembled in aqueous environment to form micelles.
Methods: The polymer-drug conjugate was characterized by NMR. The singlet oxygen (O) generation and in vitro release of Ce6 micelles were evaluated. Further, glutathione-mediated intracellular drug delivery was assessed in human alveolar adenocarcinoma cells (A549), mouse mammary carcinoma cells (4 T1) and 3D A549 spheroids.
Results: The micellar system protected Ce6 from aggregation leading to improved O generation compared to free Ce6. Due to the availability of glutathione, the disulfide bonds in the micelles were cleaved resulting in rapid release of Ce6 evident from the in vitro study. The Ce6 micelles displayed quicker drug release in presence of glutathione monoester (GSH-OEt) pre-treated A549 and 4 T1 cells compared to without pre-treated cells. In vitro phototoxicity of micelles displayed enhanced toxicity in 10 mM GSH-OEt pre-treated A549 and 4 T1 cells compared to untreated cells. As anticipated, Ce6 micelles showed lower drug release in presence of 0.1 mM of buthionine sulfoximine (BSO) pretreated A549 and 4 T1 cells exhibiting lower phototoxicity. Further, A549 3D spheroids treated with Ce6 micelles showed significant inhibition in growth, enhanced phototoxicity, and cellular apoptosis in comparison to free Ce6.
Conclusion: The above results showed that the developed strategy could be effective in improving the PDT efficacy of Ce6, and the developed polymeric micellar system could be utilized as a PDT regimen for cancer.
Chlorin e6: a promising photosensitizer of anti-tumor and anti-inflammatory effects in PDT.
Yu H, Huang Z, Wu J, Zhao Z, Hua Y, Yang Y Nanomedicine (Lond). 2025; 20(4):389-400.
PMID: 39877963 PMC: 11812356. DOI: 10.1080/17435889.2025.2456450.
Naikwadi N, Paul M, Biswas S, Chitlange S, Wavhale R Sci Rep. 2024; 14(1):31547.
PMID: 39733210 PMC: 11682353. DOI: 10.1038/s41598-024-83393-5.
Ju R, Wu F, Tian Y, Chu J, Peng X, Wang X Drug Des Devel Ther. 2023; 17:403-418.
PMID: 36798807 PMC: 9926987. DOI: 10.2147/DDDT.S387788.
Potential and Progress of 2D Materials in Photomedicine for Cancer Treatment.
Bhatt H, Pena-Zacarias J, Beaven E, Zahid M, Ahmad S, Diwan R ACS Appl Bio Mater. 2023; 6(2):365-383.
PMID: 36753355 PMC: 9975046. DOI: 10.1021/acsabm.2c00981.
Nanotherapeutic Intervention in Photodynamic Therapy for Cancer.
Itoo A, Paul M, Padaga S, Ghosh B, Biswas S ACS Omega. 2022; 7(50):45882-45909.
PMID: 36570217 PMC: 9773346. DOI: 10.1021/acsomega.2c05852.